Homepage

Unlocking
Precision Biomarkers
for Neurology

Objective, accurate biomarkers of brain function, built on decades of research and powered by AI.

Technology

The Future of Brain Function Measurement

With ease-of-use as a first principle, our platform employs computer vision and machine learning to produce dozens of valuable oculometric measures. With these measures, meaningful clinical insights are delivered across key aspects of brain function.

Learn more

Publications

  • Parkinsonism & Related Disorders

Monitoring Parkinson’s Progression: Eye Movements vs. MDS-UPDRS III

2025
  • Neurology

Correlations between traditional disability assessment and oculometric measures in Multiple Sclerosis

2024
  • Frontiers in Digital Health

Advancements in eye movement measurement technologies for assessing neurodegenerative diseases

2024
  • Applied science

Video-based gaze detection for oculomotor abnormality measurements

2024
  • Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Changes in saccadic intrusions over time as an objective biomarker to follow ALS disease progression

2024
  • Journal of Neural Transmission

Oculometric measures as a tool for assessment of clinical symptoms and severity of Parkinson’s disease

2023
  • Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Correlation between oculometric measures and clinical assessment in ALS patients participating in a phase IIb clinical drug trial

2023
  • Acta Ophthalmologica (Copenhagen)

Validation of a novel software-based platform to extract oculometric measures

2022

Clinical Partnerships

NeuraLight is a part of multiple clinical partnerships for different CNS diseases conducted in leading medical centers worldwide.

Learn more

Partnerships

Learn how precision biomarkers are revolutionizing neurology

Contact Us